Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction TPF vs CCRT in Hypopharyngeal and Base of Tongue Cancer
NCT01312350Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Nov 2010
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, cisplatin, fluorouracil in hypopharyngeal cancer, base of tongue cancer (BOTC), sponsored by Samsung Medical Center. Started Nov 2010; status: completed.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
hypopharyngeal cancerbase of tongue cancer (BOTC)
Beyond the preview
Go deeper on NCT01312350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01312350.